Thomas Nador – CEO – Buru Energy (ASX:BRU) is an oil and gas producer and explorer with its core area of activity in the in the northwest Western Australia in the onshore Canning Basin. The Company is also actively participating in the new energy economy with interests in natural hydrogen, CCS and battery minerals.
Copyright 2023 – Finance News Network
Source: Finance News Network
07 Oct 2022 - Stealth Global Holdings Limited (ASX:SGI) Group Managing Director Michael Arnold discusses the business offering, M&A activity, clients, 2025 strategy and financial targets.
Read More27 Jul 2023 - The European Bank for Reconstruction and Development has agreed to invest 6 million euros to support European Metals Holdings' (ASX:EMH) development of the Cinovec lithium project in the Czech Republic.
Read More30 Sep 2019 - Symposium, Managing Director, Kerry Stevenson talks about the importance of gold in a diversified portfolio, its successful performance over the past 12 months and all that’s on offer at this year’s event, 24-26 October, Sydney Sofitel Wentworth.
Read More27 Mar 2024 - Empire Energy Limited (ASX:EEG) CEO Alex Underwood discusses the implications of gas shortfalls across Australia and possible sources for new supply.
Read More25 Oct 2024 - In the keynote address for the inaugural Semiconductor Australia conference, Digital Playground Co-Founder and General Partner Peter Barrett discusses Australia's potential to lead in next-generation technology.
Read More25 Mar 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More05 Feb 2020 - Centuria Metropolitan REIT (ASX:CMA) Fund Manager, Grant Nichols talks 1H20 results, portfolio metrics and guidance.
Read More15 Feb 2022 - Imdex (ASX:IMD) CEO Paul House discusses drivers behind the company's 1H22 performance, research and development, and outlook.
Read More29 Mar 2021 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt talks about the Bristol Myers Squibb trial evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in patients with previously untreated metastatic or unresectable melanoma, meeting its primary endpoint of progression-free survival and what it means for Immutep.
Read More
